methylphenidate has been researched along with Movement Disorders in 24 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The results from the literature underline the necessity of caution and patient monitoring when risperidone dosing is modified during methylphenidate therapy." | 6.72 | Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance. ( Burden, AM; Stämpfli, D; Weiler, S, 2021) |
| "We report two case histories of previously healthy patients who both developed persistent dyskinetic syndromes (spasmodic torticollis and cranial dystonia, respectively) following the intake of norpseudoephedrine (NPE) as an appetite suppressant." | 3.69 | Dyskinesias possibly induced by norpseudoephedrine. ( Dressler, D; Thiel, A, 1994) |
| " The results from the literature underline the necessity of caution and patient monitoring when risperidone dosing is modified during methylphenidate therapy." | 2.72 | Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance. ( Burden, AM; Stämpfli, D; Weiler, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (79.17) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Stämpfli, D | 1 |
| Weiler, S | 1 |
| Burden, AM | 1 |
| Marti, G | 1 |
| Fattinger, K | 1 |
| Zimmermann, H | 1 |
| Exadaktylos, A | 1 |
| Goldstein, LB | 1 |
| DENZEL, HA | 1 |
| ARRIGONI-MARTELLI, E | 2 |
| BISIANI, M | 1 |
| GENOVESE, E | 2 |
| GOLDWURM, GF | 1 |
| EISENBERG, L | 2 |
| Mendhekar, DN | 1 |
| Duggal, HS | 1 |
| Martin, DM | 1 |
| Thiel, A | 1 |
| Dressler, D | 1 |
| Extein, I | 1 |
| Sleator, EK | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Caine, ED | 1 |
| McBride, MC | 1 |
| Chiverton, P | 1 |
| Bamford, KA | 1 |
| Rediess, S | 1 |
| Shiao, J | 1 |
| Millichap, JG | 2 |
| Boldrey, EE | 1 |
| Betti, V | 1 |
| Fann, WE | 2 |
| Davis, JM | 1 |
| Wilson, IC | 1 |
| Wender, PH | 1 |
| Palatucci, DM | 1 |
| Fowler, GW | 1 |
| Zaffiri, O | 1 |
| Maritano, M | 1 |
| Sainz, A | 1 |
4 reviews available for methylphenidate and Movement Disorders
| Article | Year |
|---|---|
Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.
Topics: Attention Deficit Disorder with Hyperactivity; Combined Modality Therapy; Comorbidity; Conduct Disor | 2021 |
Amphetamines and related drugs in motor recovery after stroke.
Topics: Central Nervous System Stimulants; Dextroamphetamine; Humans; Methylphenidate; Motor Cortex; Movemen | 2003 |
Minimal brain dysfunction in children. Diagnosis and management.
Topics: Abnormalities, Multiple; Affective Symptoms; Age Factors; Amphetamine; Attention; Attention Deficit | 1973 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
3 trials available for methylphenidate and Movement Disorders
| Article | Year |
|---|---|
Studies in hyperkinetic behavior. II. Laboratory and clinical evaluations of drug treatments.
Topics: Adolescent; Amphetamine; Animals; Anticonvulsants; Central Nervous System Stimulants; Child; Higher | 1967 |
Methylphenidate in tardive dyskinesia.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Evaluation Studies as Topic; | 1973 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinic | 1967 |
18 other studies available for methylphenidate and Movement Disorders
| Article | Year |
|---|---|
Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland.
Topics: Administration, Intranasal; Adult; Central Nervous System Stimulants; Humans; Hypnotics and Sedative | 2013 |
Clinical trial of ritalin in the treatment of chronically underactive and depressed patients.
Topics: Depression; Electroencephalography; Methylphenidate; Movement Disorders | 1958 |
[Effect of phenothiazine derivatives on increased motility of the mouse].
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Chlorpromazine; Methylphenidate; Mice; Mov | 1958 |
[Effects of iproniazid on increased spontaneous motility due to central stimulants].
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Iproniazid; Methylphenidate; Movement | 1958 |
DRUG THERAPY OF OVERACTIVITY IN CHILDREN (BRIEF SUMMARY OF REMARKS).
Topics: Child; Dextromoramide; Humans; Methylphenidate; Movement Disorders; Psychomotor Agitation; Psychopha | 1963 |
Methylphenidate-induced rabbit syndrome.
Topics: Child; Dyskinesia, Drug-Induced; Humans; Male; Methylphenidate; Movement Disorders | 2006 |
Hyperkinetic behavior disorders in children: clinical results with methylphenidate hydrochloride (Ritalin).
Topics: Adolescent; Child; Child Behavior Disorders; Child, Preschool; Female; Humans; Male; Methylphenidate | 1967 |
Dyskinesias possibly induced by norpseudoephedrine.
Topics: Adult; Amphetamine; Appetite Depressants; Brain; Female; Humans; Magnetic Resonance Imaging; Methylp | 1994 |
Methylphenidate-induced choreoathetosis.
Topics: Female; Haloperidol; Humans; Methapyrilene; Methylphenidate; Middle Aged; Movement Disorders; Physos | 1978 |
Letter: Methylphenidate reaction.
Topics: Ataxia; Attention Deficit Disorder with Hyperactivity; Child; Humans; Male; Methylphenidate; Movemen | 1975 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Anta | 1975 |
Tourette's syndrome in Monroe County school children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Child, Preschool; Clonid | 1988 |
[Specific correction of extrapyramidal disorders following neuroleptoanalgesia].
Topics: Animals; Guinea Pigs; Humans; Methylphenidate; Mice; Morpholines; Movement Disorders; Myoclonus; Neu | 1966 |
Iatrogenic dyskinesia. A unique reaction to parenteral methylphenidate.
Topics: Adult; Humans; Iatrogenic Disease; Injections, Intravenous; Male; Methylphenidate; Movement Disorder | 1974 |
[Apropos of neuroleptoanalgesia: the extrapyramidal symptomatology of neuroleptics and drugs that modify such symptoms].
Topics: Anesthesia; Animals; Atropine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Movement Disor | 1965 |
Use of methylphenidate to counteract acute dystonic effects of phenothiazines.
Topics: Adult; Humans; Male; Methylphenidate; Movement Disorders; Perphenazine; Schizophrenia; Torticollis; | 1966 |
Hyperkinetic disease of children: diagnosis and therapy.
Topics: Adolescent; Adult; Aging; Brain Damage, Chronic; Child; Chlordiazepoxide; Dextroamphetamine; Humans; | 1966 |
The management of the hyperkinetic child.
Topics: Child; Child, Preschool; Chlorpromazine; Dextroamphetamine; Diphenhydramine; Environment; Family; Hu | 1966 |